First-line therapy in drug reaction with eosinophilia and systemic symptoms (DReSS): Thinking beyond corticosteroids

Affiliations

Ruud H. J. Verstegen: Department of Paediatrics, University of Toronto, Toronto, ON, Canada
Ruud H. J. Verstegen: Division of Clinical Pharmacology and Toxicology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada
Ruud H. J. Verstegen: Division of Rheumatology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada
Elizabeth J. Phillips: Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States
Elizabeth J. Phillips: Department of Dermatology, Vanderbilt University Medical Center, Nashville, TN, United States
Elizabeth J. Phillips: Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States
Elizabeth J. Phillips: Department of Pharmacology, Vanderbilt University Medical School, Nashville, TN, United States
David N. Juurlink: Department of Paediatrics, University of Toronto, Toronto, ON, Canada
David N. Juurlink: Department of Medicine, University of Toronto, Toronto, ON, Canada
David N. Juurlink: Division of General Internal Medicine, Sunnybrook, Toronto, ON, Canada
David N. Juurlink: 0Division of Clinical Pharmacology and Toxicology, Sunnybrook, Toronto, ON, Canada

Abstract

No abstracts available.